Literature DB >> 25519862

Emphysematous cystitis due to recurrent Clostridium difficile infection.

Michel E van Genderen1, Jeroen G J Jonkman2, Michiel van Rijn3, Adriaan Dees1.   

Abstract

A 78-year-old woman with long-standing obstipation presented herself to the hospital with diarrhoea and progressive abdominal cramping since 2 days. Acute abdomen developed and an emergency exploratory laparotomy was indicated, which showed no signs of bowel ischaemia. After admission to the internal ward, stool Clostridium difficile PCR was tested positive. Hence the diagnosis of pseudomembranous colitis became apparent. Abdominal imaging demonstrated multiple gas foci in the wall of the bladder and extensive pseudomembranous colitis. The patient was initially treated with oral vancomycin and secondarily with metronidazole for recurrent C. difficile infection. Resolution of diarrhoea and abdominal cramping was noted on 6-week follow-up visit. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25519862      PMCID: PMC4275727          DOI: 10.1136/bcr-2014-207265

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain.

Authors:  François Lamontagne; Annie-Claude Labbé; Olivier Haeck; Olivier Lesur; Mathieu Lalancette; Carlos Patino; Martine Leblanc; Michel Laverdière; Jacques Pépin
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 2.  Emphysematous cystitis: illustrative case report and review of the literature.

Authors:  Moti Grupper; Alexander Kravtsov; Israel Potasman
Journal:  Medicine (Baltimore)       Date:  2007-01       Impact factor: 1.889

3.  Mixed acid fermentation of glucose as a mechanism of emphysematous urinary tract infection.

Authors:  J J Huang; K W Chen; M K Ruaan
Journal:  J Urol       Date:  1991-07       Impact factor: 7.450

4.  Pseudomembranous colitis due to Clostridium difficile as a cause of perineal necrotising fasciitis.

Authors:  Thibault Duburcq; Erika Parmentier-Decrucq; Julien Poissy; Daniel Mathieu
Journal:  BMJ Case Rep       Date:  2013-01-22

Review 5.  Emphysematous cystitis: a review of the literature.

Authors:  Masayuki Amano; Taro Shimizu
Journal:  Intern Med       Date:  2012-03-01       Impact factor: 1.271

6.  Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.

Authors:  Elizabeth J Kvach; David Ferguson; Paul F Riska; Marie L Landry
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

7.  All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study.

Authors:  Marjolein P M Hensgens; Abraham Goorhuis; Olaf M Dekkers; Birgit H B van Benthem; Ed J Kuijper
Journal:  Clin Infect Dis       Date:  2013-01-08       Impact factor: 9.079

Review 8.  Emphysematous cystitis: a review of 135 cases.

Authors:  Anil A Thomas; Brian R Lane; Arun Z Thomas; Erick M Remer; Steven C Campbell; Daniel A Shoskes
Journal:  BJU Int       Date:  2007-05-17       Impact factor: 5.588

Review 9.  A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.

Authors:  Ciarán P Kelly
Journal:  JAMA       Date:  2009-02-03       Impact factor: 56.272

10.  Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.

Authors:  Marya D Zilberberg; Andrew F Shorr; Marin H Kollef
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more
  2 in total

1.  A Case of Concomitant Emphysematous Cystitis and Clostridium difficile Colitis with Pneumoperitoneum.

Authors:  Tooba Tariq; Mehdi Farishta; Asad Rizvi; Furqan B Irfan
Journal:  Cureus       Date:  2018-06-30

2.  Emphysematous cystitis as a potential marker of severe Crohn's disease.

Authors:  S M Mahmudul Hasan; Baljinder S Salh
Journal:  BMC Gastroenterol       Date:  2022-04-11       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.